🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
JAN
$JANX
🔒 US EquitiesJanux Therapeutics Inc
AVG HISTORICAL GAP
-0.20%
MAX GAP RECORD
-12.72%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $JANX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$JANX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 05, 2026 Earnings Release 2026-11-05 (AFTER CLOSE (21:00)) | 🔮 UPCOMING 🔒 |
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
-2.30%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
-0.69%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE) |
-1.59%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
+1.67%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE) |
-1.46%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+0.16%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE) |
+1.12%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.5%
Bullish Gaps (7)
Bearish Gaps (4)
Neutral / Flat (3)
📖 Intelligence Summary
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗